Table 1 :
Age range in years (median) | 32-67 (45) |
|---|---|
On HAART (%) | 9 (82%) |
CD4+ cell count/µL range (median) | 35-730 (416) |
HIV viral copies/mL range (median) | <75-172,966 (<75) |
Treatment duration range (median) | 7 wks-6 mo (20 wks) |
Clinically improved (%) | 6 (55%) |
Perianal irritation (%) | 8 (73%) |
Anal fissure (%) | 1 (9%) |
Perianal HSV (%) | 1 (9%) |
Decreased dosing frequency (%) | 6 (55%) |
Discontinued (%) | 1 (9%) |